Recent Blog Posts
November 2025 Newsletter: Pharmalys gives the floor to its Employees
Highlights from the final Pharmalys Voice Meeting of 2025 On September 25, 2025, Pharmalys held its third and final Pharmalys Voice meeting of the year, bringing together colleagues from across the company in a fun and interactive virtual gathering. The meeting...
September 2025 Newsletter: Drug Safety and PV: The Pharmalys Difference
Pharmacoequity: Improving Representation in Medicine and Fairness in Care Access to safe and effective medicines is a cornerstone of modern healthcare. Yet, not everyone enjoys equal benefit from the advancements in pharmaceutical research and innovation....
Mental Health Challenges among Physicians: A Critical Public Health Concern
Mental health challenges among physicians are increasingly recognised as a serious public health issue. Studies reveal alarmingly high rates of burnout* (63% of US physicians in 2022), depression (33%), anxiety (24%), post-traumatic stress disorder (10%), and a...
16 Days of Activism 2025: A Call to End Gender-Based Violence
From 25 November to 10 December each year, the global community highlights the 16 Days of Activism Against Gender-Based Violence – a period dedicated to raising awareness, driving action and engaging all sectors of society to prevent and respond to violence rooted in...
Celebrating a Milestone in GCLP Compliance!
We are thrilled to announce the successful completion of the initial GCLP accreditation audit at Hararghe Health Research Laboratory, Haramaya University College of Health and Medical Sciences, Harar, Ethiopia. The audit took place on 16–17 October 2025 and marked a...
Movember 2025: Raising Awareness for Men’s Health
November often signals the start of the festive season in many places, but for men’s health it holds a special significance: Movember. This annual campaign invites men (and those who support them) to pause, reflect and act on several critical health issues that too...
Highlights from the final Pharmalys Voice Meeting of 2025
On September 25, 2025, Pharmalys held its third and final Pharmalys Voice meeting of the year, bringing together colleagues from across the company in a fun and interactive virtual gathering. The meeting involved presentations from colleagues, engaging discussions,...
Ethiopia Reaches WHO Maturity Level 3
On 3 October 2025, Dr Mekdes Daba, Health Minister of Ethiopia, announced a major achievement for the country: the formal recognition of the Ethiopian Food and Drug Authority (EFDA) as a Maturity Level 3 (ML3) regulatory system by the World Health Organization (WHO)....
Pharmalys CEO Marieme Ba Honoured as an IMPACT WOMAN at Alumni Day 2025
In September 2025, the Ecole Supérieure Polytechnique (ESP) Alumni community gathered at the Azalaï Hotel in Dakar, Senegal, to celebrate Alumni Day, a moment to recognise excellence, leadership, and contribution to society. Among the distinguished honourees was...
Pharmalys at the Epicentre Scientific Day 2025, Institut Pasteur, Paris
In early June, Pharmalys took part in the Epicentre Scientific Day hosted at the Institut Pasteur in Paris. Representing the company, Business Development and Strategic Partnerships Associate Arthur joined researchers, NGOs, and health professionals to engage with the...










